Company / PP&E per Share
Mirum Pharmaceuticals, Inc. PP&E per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.04
FY2025
5-year range
$0.02 / $0.04
FY2021-FY2025
Trend
+58.0%
vs FY2024
Sector context
#127 of 191
Health Care
What the data says
At $0.04, Mirum Pharmaceuticals, Inc.'s pp&e per share ranks #127 of 191 in the Health Care sector. Improved from $0.02 to $0.04 over the past 2 years.
Based on SEC 10-K filings.
0.04 in FY2025 with a 5-year CAGR of -5.5%.
Improved from $0.02 to $0.04 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- -5.5%
- 10-Year CAGR
- -
Sector benchmark
#127 of 191 in Health CareTop 66% of 191This company $0.04 Sector average $18.90
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 58.0% year-over-year.
- Ranks #127 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
- Lowest pp&e per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | +58.0% |
| FY2024 | $0.02 | +27.6% |
| FY2023 | $0.02 | -36.1% |
| FY2022 | $0.03 | -9.3% |
| FY2021 | $0.03 | -35.7% |
| FY2020 | $0.05 | -57.1% |
| FY2019 | $0.12 | - |
| FY2018 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026